ISPUB.com / IJGO/7/2/10921
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Gynecology and Obstetrics
  • Volume 7
  • Number 2

Original Article

Unexplained Ten Consecutive Early Third Trimester Intrauterine Fetal Deaths: A Diagnostic Dilemma

A Halder

Keywords

antiphospholipid like syndrome, recurrent iud, turbid liquor amni and placental pathology, very low maternal alpha feto protein

Citation

A Halder. Unexplained Ten Consecutive Early Third Trimester Intrauterine Fetal Deaths: A Diagnostic Dilemma. The Internet Journal of Gynecology and Obstetrics. 2006 Volume 7 Number 2.

Abstract

This report presents a case of unexplained ten consecutive early third trimester intrauterine fetal deaths in the absence of any maternal detectable risk factors and in presence of normal fetal growth. Detectable associations in tenth pregnancy were very low maternal serum alpha feto protein (<0.15 MOM MSAFP), turbid liquor amni and extensive placental pathology viz., fibrosis, hyalinization, infarction, narrowing as well as poor vascularization of chorionic vessels.

 

Introduction

Recurrent early third trimester fetal deaths may result from variety of causes like chronic maternal illness, Rh-isoimmunization, syphilis, uterine anomalies and chromosomal abnormality. Several reports also have indicated an association between recurrent fetal death with antiphospholipid antibodies1,2,3, congenital protein C or protein S deficiency4,5, activated protein C resistance6, lupus anticoagulant7, prothrombotic mutations8 and disorders of maternal-placental interface, such as feto-maternal hemorrhage9 as well as maternal floor infarction10. In some cases primary placetal pathology viz chorio-angiomas11 of placenta, primary avascularity of placenta12 and chronic villitis of unknown origin13 has been implicated. However, universal acceptance of the later two associations are still lacking. We here report a case of ten consecutive early third trimester (27-31 weeks) fetal losses with very low maternal serum alpha feto protein (<0.15 MOM MSAFP), turbid liquor amni and extensive placental pathology viz., fibrosis, hyalinization, infarction, narrowing as well as poor vascularization of chorionic vessels.

Case Report

A macerated stillborn female fetus was referred for fetal autopsy. The fetus was delivered at 31 weeks of gestation to para ten, hindu, brahmin, middle class mother who had noticed decreased fetal movements three weeks prior to delivery and loss of fetal movement 4-5 days before the delivery. The mother was 32 years and father 38 years old at the time of birth of the child. There was no history of consanguinity. The present pregnancy had remained uncomplicated untill decreased fetal movements were noticed around 27th week of pregnancy. At the onset of decrease in fetal movement an obstetric ultrasound was carried out privately that showed illsustained fetal breathing (at 27 weeks) and turbid liquor amni. All other fetal parameters were normal. Follow up ultrasound at the time of loss of fetal movement revealed fetal death at 30 weeks of gestation. Labour was induced by oxytocin infusion and a female fetus weighing 1.535 Kg was delivered vaginally. Autopsy findings revealed no intrauterine growth retardation (good subcutaneous fat and normal weight), no internal or external malformation & no umbilical cord pathology. However, thymus & placenta were hypoplastic and placenta was firm (nonspongy). Placental histopathology examination showed extensive placental fibrosis, hyalinization, infarction, narrowing as well as poorly vascularization of chorionic vessels (Fig.1 & 2).

Figure 1
Figure 1: (X50 magnification) and Figure 2: (X125 magnification). Section of placenta showing fibrosis, hyalinisation, poor vascularisation and narrowing of vessel lumen.

Figure 2

Similar autopsy findings were reported in previous pregnancy. Almost similar obstetrics history had followed in previous pregnancies. The mother was under care of private obstetricians throughout most pregnancies and fetal dath was unstoppable even after antiplatelet therapy in last pregnancy. All the fetuses were normal externally; seven were male and three were female. There were no signs of growth retardation in any of fetuses. The couple was investigated in detail in 10th pregnancy and also in the interval period between 9th & 10th pregnancy. The findings are summarised in Table1. The mother was not known to have any chronic disease, however, she had two episodes of right sided hemiparesis at the age of 8 years and 14 years from which she had recovered fully.

Family history revealed no similar fetal losses. However, multiple sets of twin pregnancies were reported in first degree relatives of the couple (both sides).

Discussion

Recurrent early third trimester fetal death may remain unexplained inspite of indepth investigation. The case which is described in this report is preferably termed as inadequately explained despite indepth investigations. As all her ten pregnancies ended in the same fashion and almost at the same period, we presume a common underlying etiopathologic factor. Our prime suspects are antiphospholipid like syndrome/antiphospholipid like syndrome and inherited thrombophilias (protein S deficiency, activated protein C resistance, prothrombotic mutations, etc). Primary antiphospholipid syndrome (APS) is unlikely in the absence of negative investigations (lupus anticoagnlant, platelet count, VDRL test, complements and anticardiolipin antibody). However, adverse pregnancy outcome has been reported in patients with APS with low positive autoantibody titre14 as in our case. In addition Branch et al15 earlier reported that some patients with this history may produce antiphosphatidylserine antibody. Similarly, Triplett et al16 reported that patient with APS may have positive reaction only against phosphatidylserine or phosphatidylinositol. Although testing for anticardiolipin antibody may provide some insight into patient with APS, testing for phosphatidylserine antibody identifies some rare patient who are non-reactive for anticardiolipin and lupus anticoagulant17. Antiphospholipid like syndrome (in presence of absent autoantibodies)18 could be the possibility for the underlying cause and is supported by the history of recurrent trainsient ischemic attack (in the form of hemiparesis), patern of recurrent fetal death after detection of fetal heart and placental histopathology viz. infarction, intravascular fibrin deposition and fibrosis18although placental changes could be partly due to post mortem changes. Placental fibrosis is commonly seen with macerated stillbirth (long standing intrauterine death). However, it is very unlikely that placental histologic changes are solely postmortem as indirect evidences (low MSAFP, turbid liquor amni, decrease fetal movement 2-3 week before fetal death and thymic hypoplasia) indicate its antenatal onset. Very low maternal alpha feto protein can be seen with chromosomal abnormality (trisomy 21, trisomy 18, 48,XXYY and triploidy)19,20,21, placental chorioangiomas11 or placental fibrosis. Very low MSAFP levels with later condition can be explained by lack of transfer of AFP from fetus to mother because of placental fibrosis and hypovascularity. The reason for turbid liquor is not apparent. However, it was not due to oligohydramnios or amniotic infection or bleeding or meconium in amniotic fluid. Placental fibrosis and hypovascularity may probably the end result of chronic villitis of immunologic origin through antiphospholipid or antiphospholipid-like syndrome18, activated protein C resistance6, prothrombotic mutations8 and anti-annexin V autoantibodies22. Placental fibrosis may also be seen with methyl parathion exposure23,24, hyperthermia25, hypoxia26,27 and transforming growth factor-beta overactivity26,28. Chronic hypoxia is unlikely to be the underlying cause (commonly seen with pregnancy induced hypertension) as this results in minimal fibrosis of the villi, whereas a marked fibrosis with increase in stromal connective tissue and villous avascularity results from thrombosis in main stem and surface vessels29 as seen with prothrombotic mutations8 and antiphospholipid syndrome18.

Possibilities like cogenital protein C deficiency, uterine anomalies, balanced chromosomal translocation in parents, etc were excluded by approporiate investigations (Table 1). Similarly, monogenic, polygenic, multifactorial, uniparental disomy and genomic imprinting as underlying cause is unlikely as none recurr in 100% offsprings. Maternal floor infarction or fetomaternal hemorrhage as cause is also unlikely in the absence of high MSAFP30.

In conclusion we feel that evaluation of recurrent unexplained fetal death is incomplete unless it directs investigation towards detailed inmunologic (beyond anticardiolipin & lupus anticoagulant), inherited thrombophilias as well as placental pathology. Time has come to stress pathology of placenta as a factor in fetal demise and not only as part of epiphenomena.

Figure 3
Table 1: Summary of Investigations

Correspondence to

Dr. Ashutosh Halder, Associate Professor, Department of Reproductive Biology, All India Institute of Medical Sciences, New Delhi 110029, India Phone: 011-26593304 ext. 4211 Mobile: 9313309579 Email: ashutoshhalder@yahoo.co.in

References

1. Nilsson IM, Astedt B, Hedner U and Berezin D (1975): Intrauterine death and circulatory anticoagulant (antithromboplastin). Acta Med. Scand. 197; 153-156.
2. Harris EN, Charave AE and Hughes GR (1985) : Antiphospholipid antibodies. Clin. Rheum. Dis. 11; 591-609.
3. Lockshin MD, Druzin ML and Goei S (1985) : Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematous. N. Engl. J. Med. 313; 152-156.
4. Trauscht-Van Horn JJ, Capeless EL, Easterling TR and Bovill EG (1992) : Pregnancy loss and thromobosis with protein C deficiency. Am. J. Obstet. Gynecol. 167 (4 pt 1); 968-972.
5. Tharakan T, Baxi LV and Diuguid D (1993) : Protein S deficiency in pregnancy : A case report. Am. J. Obstet. Gynecol. 168; 141-142.
6. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol. 1997; 97: 551-554.
7. Carreras LD, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2(8607): 393-394.
8. Grandone E, Colaizzo D, Brancaccio V, Ciampa A, Di Minno G, Margaglione M. Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica 2002; 87:1118-1119.
9. Benirschke K and Kaufmann P (1990) : Pathology of the Human Placenta. 2nd Edition. New York, NY. Springer-Verlag Ny inc.
10. Clewell WH and Manchester DK (1983) : Recurrent maternal floor infarction. A preventable cause of fetal death. Am. J. Obstet. Gynecol. 147; 346-347.
11. Gallot D, Sapin V, Beaufrere AM, Boda C, Laurichesse-Delmas H, Dechelotte P, Lemery D. Recurrence of multiple chorio-angiomas: a case-report. Gynecol Obstet Fertil. 2003; 31: 943-947.
12. Fox H (1987) : General pathology of the placenta. In : Fox H. ed. Obstetrical and Gynecological pathology. New York, NY : Churchill Livingstone Inc. 2; 972-1000.
13. Russell P, Atkinson K and Krishnan L (1980) : Recurrent reproductive failure due to severe plaental villitis of unknown etiology. J. Reprod. Med. 24; 93-98.
14. Branch DW, Silver RM, Blackwell JL, Reading JC and Scott JR (1992) : Outcome of treated pregnancies in women with antiphospholipid syndrome : an update of the utah experience. Obstet. Gynecol. 80; 614-620.
15. Branch DW, Rote NS and Dostal D (1987) : Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Imm Immunopath. 42;63-67.
16. Triplett DA, Brandt JT, Musgrave KA and Orr CA (1988) : The relationship between lupus anticoagulant and antibodies to phospholipids. JAMA. 259; 550-554.
17. Rote NR, Dostal-Johnson D, Branch DW (1990) : Antiphospholipid antibodies and recurrent pregnancy loss. Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am. J. Obstet. Gynecol. 163; 575-584.
18. Van Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004; 25: 642-648.
19. Hamada H, Koresawa M, Kubo T. A case of fetal triploidy associated with low maternal serum alpha-fetoprotein. Nippon Sanka Fujinka Gakkai Zasshi. 1991; 43: 799-802.
20. Hsu JJ, Hsieh CC, Chiu TH, Soong YK. The relationship between weights of fetuses with autosomal trisomies and low maternal serum alpha-fetoprotein. Changgeng Yi Xue Za Zhi. 1992; 15: 33-38.
21. Nyberg RH, Karhu R, Karikoski R, Simola KO. The 48,XXYY syndrome: a case detected by maternal serum alpha-fetoprotein screening. Prenat Diagn. 1994; 14: 644-645.
22. Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol. 1999 Apr;180(4):1008-16.
23. Edwards FL, Tchounwou PB. Environmental Toxicology and Health Effects Associated with Methyl Parathion Exposure - A Scientific Review. Int J Environ Res Public Health. 2005; 2: 430-441.
24. Levario-Carrillo M, Olave ME, Corral DC, Alderete JG, Gagioti SM, Bevilacqua E. Placental morphology of rats prenatally exposed to methyl parathion. Exp Toxicol Pathol. 2004; 55: 489-496.
25. Padmanabhan R, Al-Menhali NM, Ahmed I, Kataya HH, Ayoub MA. Histological, histochemical and electron microscopic changes of the placenta induced by maternal exposure to hyperthermia in the rat. Int J Hyperthermia. 2005; 21: 29-44.
26. Chen CP, Yang YC, Su TH, Chen CY, Aplin JD. Hypoxia and transforming growth factor-beta 1 act independently to increase extracellular matrix production by placental fibroblasts. J Clin Endocrinol Metab. 2005; 90: 1083-1090.
27. Chen CP, Aplin JD. Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen. Placenta. 2003; 24: 316-325.
28. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect. 1999 Dec;1(15):1349-65.
29. Fox H 1997 Pathology of the placenta. 4th ed. London: Saunders
30. Katz VL, Bowes WA and Sierkh AE (1987) : Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein. Am. J. Perinatol. 4; 225-228.

Author Information

Ashutosh Halder, MD, DM
Associate Professor, Department of Reproductive Biology, All India Institute of Medical Sciences

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy